{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:39:34Z","timestamp":1790995174222,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.pnpbp.2011.12.001","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T22:49:29Z","timestamp":1323643769000},"page":"16-20","source":"Crossref","is-referenced-by-count":68,"title":["CB2: Therapeutic target-in-waiting"],"prefix":"10.1016","volume":"38","author":[{"given":"Brady K.","family":"Atwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Straiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.12.001_bb0005","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2174\/092986708784567716","article-title":"Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists","volume":"15","author":"Ashton","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0015","unstructured":"Atwood BK, Wager-Miller J, Haskins C, Straiker A, Mackie K. Functional selectivity in CB2 cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB2 ligands. Mol Pharmacol. In press."},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0020","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/07853890903121025","article-title":"Cannabinoids and the skeleton: from marijuana to reversal of bone loss","volume":"41","author":"Bab","year":"2009","journal-title":"Ann Med"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/138955709787001785","article-title":"Cannabinoid type 2 receptor as a target for chronic-pain","volume":"9","author":"Beltramo","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0030","doi-asserted-by":"crossref","first-page":"20397","DOI":"10.1074\/jbc.274.29.20397","article-title":"Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses","volume":"274","author":"Bouaboula","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0167-4781(02)00341-X","article-title":"Cloning and molecular characterization of the rat CB2 cannabinoid receptor","volume":"1576","author":"Brown","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bjp.0707527","article-title":"The peripheral cannabinoid receptor knockout mice: an update","volume":"153","author":"Buckley","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0050","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1124\/mol.65.4.999","article-title":"Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism","volume":"65","author":"Carrier","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0055","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1517\/13543784.16.7.951","article-title":"Targeting cannabinoid agonists for inflammatory and neuropathic pain","volume":"16","author":"Cheng","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0060","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despres","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1","article-title":"Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB","volume":"422","author":"Egertova","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0075","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ijo.2009.132","article-title":"Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions","volume":"33","author":"Fong","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.neuro.27.070203.144206","article-title":"Desensitization of G protein-coupled receptors and neuronal functions","volume":"27","author":"Gainetdinov","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0090","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.bbamcr.2011.05.010","article-title":"Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway","volume":"1813","author":"Grimsey","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0100","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1046\/j.1460-9568.2000.00217.x","article-title":"Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations","volume":"12","author":"Hajos","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0110","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.1142265","article-title":"Attenuation of allergic contact dermatitis through the endocannabinoid system","volume":"316","author":"Karsak","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0115","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1074\/jbc.M510871200","article-title":"Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils","volume":"281","author":"Kurihara","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tips.2011.02.013","article-title":"Personalized medicine can pave the way for the safe use of CB receptor antagonists","volume":"32","author":"Lazary","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","article-title":"Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands","volume":"8","author":"Liu","year":"2009","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/JMN:26:2-3:253","article-title":"Composition and function of g protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity","volume":"26","author":"Luttrell","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2007.06.002","article-title":"GPCR functional selectivity has therapeutic impact","volume":"28","author":"Mailman","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000282100","article-title":"Endocannabinoids and their role in fatty liver disease","volume":"28","author":"Mallat","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1476-5381.2009.00154.x","article-title":"Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242","volume":"158","author":"Mancini","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/138955708783955935","article-title":"Indoles and related compounds as cannabinoid ligands","volume":"8","author":"Manera","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","article-title":"Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli","volume":"95","author":"Maresz","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156802608783498014","article-title":"Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor","volume":"8","author":"Marriott","year":"2008","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/7854_2009_16","article-title":"Cannabinoids and anxiety","volume":"2","author":"Moreira","year":"2010","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tips.2010.05.006","article-title":"Do cannabinoids have a therapeutic role in transplantation?","volume":"31","author":"Nagarkatti","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0185","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/178697b0","article-title":"Receptor occupancy and tissue response","volume":"178","author":"Nickerson","year":"1956","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0190","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1074\/jbc.M413260200","article-title":"Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear","volume":"280","author":"Oka","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0195","doi-asserted-by":"crossref","first-page":"e1640","DOI":"10.1371\/journal.pone.0001640","article-title":"Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects","volume":"3","author":"Onaivi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0200","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2174\/092986710790980041","article-title":"Cannabinoid CB(2) receptors in health and disease","volume":"17","author":"Patel","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0205","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/35094577","article-title":"Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors","volume":"2","author":"Pierce","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/mi.11.1.6","article-title":"Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?","volume":"11","author":"Seely","year":"2011","journal-title":"Mol Interv"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0215","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11481-009-9169-z","article-title":"Identification of transcription start sites and preferential expression of select CB2 transcripts in mouse and human B lymphocytes","volume":"4","author":"Sherwood","year":"2009","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0220","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/jpet.105.089474","article-title":"Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors","volume":"315","author":"Shoemaker","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-6147(02)01993-4","article-title":"Mechanisms of inverse agonism at G-protein-coupled receptors","volume":"23","author":"Strange","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0230","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/13543770903436505","article-title":"Latest advances in cannabinoid receptor agonists","volume":"19","author":"Thakur","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0235","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-60327-317-6_26","article-title":"Immunoprecipitation and phosphorylation of G protein-coupled receptors","volume":"552","author":"Thomas","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0240","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0250","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1523\/JNEUROSCI.0786-09.2009","article-title":"Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K\/Akt pathway","volume":"29","author":"Viscomi","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0255","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB receptors modulate cocaine's actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pnpbp.2011.12.001_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bjp.0706838","article-title":"In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?","volume":"149","author":"Yao","year":"2006","journal-title":"Br J Pharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T13:12:28Z","timestamp":1742044348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611003514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0278584611003514"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.12.001","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}